NCAM1 and graft versus host disease: In the present study, we found significantly lower levels of T-cells expressing the NK-cell markers CD56 (on CD4+ T-cells) and CD94 (on naïve and terminally differentiated T-cells) in samples from donors before MLC in the GVHD group (Figure 2).